Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
sirukumab interleukin-6 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Rheumatoid Arthritis[MeSHID:D001172]
Disease[MeSHID:D004194]		 2.55 phase 3 inhibitor
sirukumab interleukin-6 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Giant Cell Arteritis[MeSHID:D013700]
Lupus Erythematosus
Cutaneous[MeSHID:D008178]
Major Depressive Disorder[MeSHID:D003865]
Rheumatoid Arthritis[MeSHID:D001172]		 2.55 phase 3 inhibitor
sirukumab interleukin-6 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Unipolar Depression[MeSHID:D003866]
Giant Cell Arteritis[MeSHID:D013700]
Lupus Erythematosus
Cutaneous[MeSHID:D008178]
Major Depressive Disorder[MeSHID:D003865]
Rheumatoid Arthritis[MeSHID:D001172]		 2.55 phase 3 unknown
sirukumab interleukin-6 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Rheumatoid Arthritis[MeSHID:D001172]
Disease[MeSHID:D004194]		 2.55 phase 3 unknown
click here to return to the previous page